Electronic cigarettes, or vapes, are widely used and available in hundreds of different types and flavors, yet researchers lack information about the everyday e-cigarette habits of young adults. The National Institutes of Health, in partnership with the U.S. Food and Drug Administration, has funded a University of Oklahoma study that will investigate how, when and why young adults use e-cigarettes and how that use may relate to health risks. The results will help the FDA make decisions about regulating the makers of e-cigarette products.

Four faculty members from the University of Oklahoma have been named 2025-26 Fellows of the Southeastern Conference Academic Leadership Development Program, an initiative aimed at preparing the next generation of academic leaders to meet the evolving challenges of higher education.

The University of Oklahoma College of Dentistry recently hosted the Discovering Dentistry Symposium presented by the non-profit organization, Planet Smilez, to inspire and educate middle and high school students about careers in dentistry as part of an effort to address critical workforce gaps and improve access to care.

An international study published today in the New England Journal of Medicine sheds light on acute normovolemic hemodilution, also known as ANH, a blood conservation technique. ANH involves removing a patient’s blood before the patient goes on heart-lung bypass, and then reinfusing it toward the end of heart surgery. Long debated for its effectiveness, ANH does not appear to reduce the need for red blood cell transfusion, according to results of the global clinical trial. However, study co-author Kenichi Tanaka, M.D., professor and chair of the Department of Anesthesiology at the University of Oklahoma College of Medicine, said the outcomes necessitate further scrutiny and may not be applicable to U.S. patients.

Mariana Georgeta Varga, MD, joined the Department of Neurology at the University of Oklahoma College of Medicine and OU Health as the inaugural Medical Director of the Movement Disorder Center. Dr. Varga is a graduate of the OU neurology residency program and the Cleveland Clinic Foundation.